Llwytho...
Sweet’s Syndrome Induced by Aromatase Inhibitor in the Treatment of Early Breast Cancer
BACKGROUND: Breast cancer is the most commonly diagnosed cancer in women, mainly at an early stage, allowing treatment with curative intent. Aromatase inhibitors are widely used in the adjuvant treatment of oestrogen receptor-positive breast cancer, mainly in postmenopausal women. The most frequent...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Eur J Case Rep Intern Med |
|---|---|
| Prif Awduron: | , , , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
SMC Media Srl
2020
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7083188/ https://ncbi.nlm.nih.gov/pubmed/32206641 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12890/2020_001435 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|